Clinical Trials Logo
  1. Home
  2. Liver Metastasis Colon Cancer
  3. NCT04686942
  4. Details
NCT04686942 Clinical Trial

Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cm

Liver Metastasis Colon Cancer Clinical Trial

Official title:
Evaluation of Contrast Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cm

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04686942
Other study ID # Sonazoid001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 17, 2020
Est. completion date December 30, 2023

Study information
Verified date December 2020
Source Sun Yat-sen University
Contact Jiliang Qiu
Phone 862087343114
Email qiujl@sysucc.org.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Preoperative chemotherapy is often used for patients with colorectal cancer liver metastasis (CLM). Many small CLMs (<=2cm) may disappear after chemotherapy, while most of these are still alive. Ultrasonography (US) is a common imaging modality for the intraoperative detection tumor. Sonazoid is new echo-contrast agent, which is more stable and sensitive for detecting of small tumor. Investigators initially this prospective study to compare the detection performance before and after using sonazoid.

Recruitment information / eligibility
Status Recruiting
Enrollment 550
Est. completion date December 30, 2023
Est. primary completion date December 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Pathology confirmed colorectal adenocarcinoma - One or more liver metastases less than 2 cm - Multidisciplinary team recommend to perform preoperative chemotherapy - Have baseline EOB-MR before chemotherapy Exclusion Criteria: - Could not fulfill the criteria of no evidence of disease (NED) after hepatic resection/ablation/radiotherapy - With other malignancies

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• After sonazoid
0.015ml/mg sonazoid enhanced US to detection of liver metastases.

Locations
Country Name City State
China Sun Yat-sen University Cancer Center Guangzhou

Sponsors (1)
Lead Sponsor Collaborator
Sun Yat-sen University

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary sensitive of detection tumor Change of the sensitivity detection liver tumors when using sonazoid enhanced ultrasound 6 months
See also
  Status Clinical Trial Phase
Suspended NCT04108481 - Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer Phase 1/Phase 2
Recruiting NCT03562234 - The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver Metastases
Recruiting NCT03732235 - TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer
Recruiting NCT06126419 - Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration N/A
Active, not recruiting NCT05616039 - I-FIGS Feasibility Study N/A
Withdrawn NCT05175092 - Living Donor Liver Transplantation for CRC Liver Metastases N/A
Recruiting NCT04798898 - Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation N/A
Not yet recruiting NCT06053996 - Hepatopulmonary Radio-sterilization With Immunotherapy N/A
Not yet recruiting NCT06071052 - TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens N/A
Recruiting NCT04491929 - Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases
Not yet recruiting NCT06050200 - TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery N/A
Enrolling by invitation NCT03444194 - Treatment Response Evaluation in Patients With Non-resectable Colorectal Liver Metastases A Feasibility Study N/A
Not yet recruiting NCT05884723 - Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis N/A
Not yet recruiting NCT06185556 - COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases Phase 2/Phase 3
Recruiting NCT05755672 - On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Recruiting NCT04595266 - Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease Phase 2
Recruiting NCT04701281 - Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer Phase 1/Phase 2
Recruiting NCT05775146 - SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases Phase 2
Recruiting NCT06200831 - Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases N/A
Active, not recruiting NCT04046445 - Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer Phase 1